1. Home
  2. VERB vs APVO Comparison

VERB vs APVO Comparison

Compare VERB & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERB
  • APVO
  • Stock Information
  • Founded
  • VERB 2014
  • APVO 2016
  • Country
  • VERB United States
  • APVO United States
  • Employees
  • VERB N/A
  • APVO N/A
  • Industry
  • VERB Other Consumer Services
  • APVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • VERB Consumer Discretionary
  • APVO Health Care
  • Exchange
  • VERB Nasdaq
  • APVO Nasdaq
  • Market Cap
  • VERB 4.7M
  • APVO 5.4M
  • IPO Year
  • VERB N/A
  • APVO N/A
  • Fundamental
  • Price
  • VERB $4.10
  • APVO $1.38
  • Analyst Decision
  • VERB Strong Buy
  • APVO Strong Buy
  • Analyst Count
  • VERB 1
  • APVO 1
  • Target Price
  • VERB $100.00
  • APVO $296.00
  • AVG Volume (30 Days)
  • VERB 33.5K
  • APVO 5.2M
  • Earning Date
  • VERB 05-09-2025
  • APVO 05-07-2025
  • Dividend Yield
  • VERB N/A
  • APVO N/A
  • EPS Growth
  • VERB N/A
  • APVO N/A
  • EPS
  • VERB N/A
  • APVO N/A
  • Revenue
  • VERB $895,000.00
  • APVO N/A
  • Revenue This Year
  • VERB $36.76
  • APVO N/A
  • Revenue Next Year
  • VERB N/A
  • APVO N/A
  • P/E Ratio
  • VERB N/A
  • APVO N/A
  • Revenue Growth
  • VERB 1320.63
  • APVO N/A
  • 52 Week Low
  • VERB $4.29
  • APVO $0.94
  • 52 Week High
  • VERB $53.60
  • APVO $180.19
  • Technical
  • Relative Strength Index (RSI)
  • VERB 33.75
  • APVO 38.63
  • Support Level
  • VERB $4.51
  • APVO $0.94
  • Resistance Level
  • VERB $5.08
  • APVO $3.61
  • Average True Range (ATR)
  • VERB 0.51
  • APVO 0.53
  • MACD
  • VERB -0.10
  • APVO 0.02
  • Stochastic Oscillator
  • VERB 0.00
  • APVO 22.04

About VERB Verb Technology Company Inc.

Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. Available in over 60 countries and in mobile and desktop versions, it includes verbLIVE an interactive livestream eCommerce, shoppable video and webinar, verbCRM a customer relationship management, verbTEAMS a self on-boarding version of verbCRM with built-in verbLIVE and salesforce synchronization for small businesses, verbLEARN a learning management system and among others.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: